Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 3/20 | 0.50 |
| ▸ | DRD1 | P21728 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9350384 | 0.84 | MEN1 (0.41) | ENPP2CYP3A4CYP1A2LMNAKMT2A | |
| SCHEMBL19609051 | 0.82 | ENPP2 (0.58) | ENPP2DRD2DRD1TAAR1CYP3A4 | |
| SCHEMBL30737423 | 0.79 | DRD2 (0.57) | ENPP2DRD2DRD1TAAR1CYP3A4 | |
| SCHEMBL1233598 | 0.78 | MMP3 (0.65) | ENPP2DRD2DRD1TAAR1CYP3A4 | |
| SCHEMBL3689366 | 0.78 | ENPP2 (0.45) | ENPP2 | |
| SCHEMBL7773782 | 0.78 | MIF (0.55) | ENPP2DRD2DRD1TAAR1CYP3A4 | |
| SCHEMBL9508918 | 0.78 | ENPP2 (0.54) | ENPP2DRD2DRD1TAAR1CYP3A4 | |
| SCHEMBL909770 | 0.78 | DRD2 (0.55) | ENPP2DRD2DRD1TAAR1CYP3A4 | |
| SCHEMBL2809012 | 0.75 | ENPP2 (0.50) | ENPP2DRD2DRD1TAAR1CYP3A4 | |
| Resorcinol SCHEMBL18335395 | 0.75 | ALDH1A1 (0.60) | ENPP2DRD2DRD1TAAR1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1689816-B1 | CURABLE SILICONE COMPOSITION AND CURED PRODUCT THEREOF | DOW CORNING TORAY CO LTD (JP) | 2010-07-14 | — | — | EP | claimed |
| EP-0922050-B1 | 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES | ABBOTT LAB (US) | 2003-07-30 | — | — | EP | claimed |
| EP-0475437-B1 | Organocyclosiloxane and method for its preparation | DOW CORNING TORAY SILICONE (JP) | 1995-11-08 | — | — | EP | claimed |
| US-11901249-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| CN-112119104-B | Epoxy (meth) acrylate resin composition, curable resin composition, cured product, and article | DIC株式会社 | 2023-09-29 | — | — | CN | disclosed |
| CN-111918891-B | Curable composition and cured product thereof | DIC株式会社 | 2023-02-28 | — | — | CN | disclosed |
| CN-112105661-B | Acid group-containing (meth) acrylate resin composition, curable resin composition, cured product, and resin material for solder resist | DIC株式会社 | 2023-02-24 | — | — | CN | disclosed |
| US-11548977-B2 | Active ester resin and composition and cured product using the same | DIC CORPORATION (JP) | 2023-01-10 | — | — | US | disclosed |
| CN-110770202-B | Active ester resin, and composition and cured product using same | DIC株式会社 | 2022-12-16 | — | — | CN | disclosed |
| US-20210009804-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2021-01-14 | — | — | US | disclosed |
| CN-112119104-A | Epoxy (meth) acrylate resin composition, curable resin composition, cured product, and article | DIC株式会社 | 2020-12-22 | — | — | CN | disclosed |
| CN-1354166-A | Process for preparing cyclopropane carboxylic acid ester | SUMITOMO CHEMICAL CO (JP) | 2002-06-19 | — | — | CN | disclosed |
| EP-1203760-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-08 | — | — | EP | disclosed |
| US-20020052525-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-02 | — | — | US | disclosed |
| CN-1282729-A | Preparation method of cyclopropane carboxylic acid ester | SUMITOMO CHEMICAL CO (JP) | 2001-02-07 | — | — | CN | disclosed |
| EP-1061065-A2 | Methods for producing cyclopropane carboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-12-20 | — | — | EP | disclosed |
| CN-1255489-A | Method for preparing cyclopropane carboxylic ester | SUMITOMO CHEM ENG (JP) | 2000-06-07 | — | — | CN | disclosed |
| EP-0992479-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-04-12 | — | — | EP | disclosed |
| CN-87103507-A | The preparation of propargyl oxybenzene derivative and contain the mycocide of propargyl oxybenzene derivative | — | 1988-01-13 | — | — | CN | disclosed |
| EP-0183212-A2 | Pyridazinone derivatives, preparation thereof, and insecticidal, acaricidal, nematicidal, fungicidal compositions | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020052525-A1 | Method for producing cyclopropanecarboxylates | CYP8B1, SRD5A2, CYP21A2 | ENPP2 3485/4885DRD2 645/4885DRD1 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.